Centene completed the acquisition of PANTHERx Rare Pharmacy.

Centene, a healthcare enterprise, completed the acquisition of PANTHERx Rare Pharmacy, one of the largest and fastest-growing specialty pharmacies in the United States. Financial terms were not disclosed. "Centene has a long-standing commitment to providing care to the most underserved, complex populations. PANTHERx adds a unique capability to our comprehensive pharmacy portfolio. We share a common goal of helping to remove barriers and reduce the burden for our members living with complex and rare diseases," Michael F. Neidorff, Centene Chairman, President and CEO.